Global Diabetes Drugs Market Set to Grow to $66bn by 2021
August 14, 2018
August 14, 2018
LONDON, England, Aug. 14 -- Visiongain, a independent media company, issued the following news release:
Visiongain' has launched a new pharma report Global Diabetes Drugs Market 2017-2027 (https://www.visiongain.com/report/global-diabetes-drugs-market-2017-2027/): Insulin and Insulin Analogues, DPP-4 Inhibitors, Biguanides, GLP-1 Agonists, Alpha-glucosidases, SGLT-2 Inhibitors, Sulfonylureas and Others.
The IDF (International Diabetes Federation) predicts that by 2035, . . .
Visiongain' has launched a new pharma report Global Diabetes Drugs Market 2017-2027 (https://www.visiongain.com/report/global-diabetes-drugs-market-2017-2027/): Insulin and Insulin Analogues, DPP-4 Inhibitors, Biguanides, GLP-1 Agonists, Alpha-glucosidases, SGLT-2 Inhibitors, Sulfonylureas and Others.
The IDF (International Diabetes Federation) predicts that by 2035, . . .